Amgen 
Welcome,         Profile    Billing    Logout  
 160 Products   813 Diseases   160 Products   1618 Trials   78436 News 


«12...883884885886887888889890891892893...910911»
  • ||||||||||  Ravicti (glycerol phenylbutyrate) / Immedica, Amgen
    Enrollment open:  Use of Ravicti (clinicaltrials.gov) -  Sep 23, 2013   
    P2,  N=6, Recruiting, 
    Not yet recruiting --> Recruiting
  • ||||||||||  litronesib (KF 89617) / Kyowa Kirin, Eli Lilly
    Trial completion, Metastases:  A Study of LY2523355 in Participants With Breast Cancer (clinicaltrials.gov) -  Sep 22, 2013   
    P2,  N=60, Completed, 
    Completed --> Terminated; Due to poor accrual Active, not recruiting --> Completed
  • ||||||||||  Traficet-EN (vercirnon) / Amgen
    Trial termination:  SHIELD-2: GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease (clinicaltrials.gov) -  Sep 11, 2013   
    P3,  N=229, Terminated, 
    Recruiting --> Terminated Recruiting --> Terminated; This study was terminated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.
  • ||||||||||  Avastin (bevacizumab) / Roche, dulanermin (AMG 951) / Amgen, Roche
    Trial completion, Combination therapy, Metastases:  A Study of Dulanermin Administered in Combination With Camptosar (clinicaltrials.gov) -  Sep 8, 2013   
    P1,  N=42, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  pazopanib / Generic mfg.
    Enrollment change, Metastases:  Pazopanib, Docetaxel, Prednisone Prostate (clinicaltrials.gov) -  Sep 2, 2013   
    P1,  N=36, Recruiting, 
    Active, not recruiting --> Completed N=122 --> 36
  • ||||||||||  prezalumab (AMG 557) / Amgen, AstraZeneca
    Trial initiation date:  Safety Study of AMG 557 in Subjects With Lupus Arthritis (clinicaltrials.gov) -  Aug 29, 2013   
    P1,  N=40, Recruiting, 
    Recruiting --> Terminated; Material sponsor withdrew support Initiation date: Jan 2012 --> Jun 2012